HTDK and Sofwave Enter Strategic Partnership to Accelerate Sofwave's Market Expansion in China

Recently, HTDK and Sofwave Medical (TASE: SOFW) announced the signing of an exclusive commercialization strategic cooperation agreement for the Chinese mainland market, to help Sofwave expand into the Chinese market. Sofwave is a globally leading company focused on the production of energy-based non-invasive medical aesthetic devices. This strategic cooperation is an important step for Sofwave to expand into the Chinese market. HTDK will leverage its deep industry experience and excellent professional capabilities to comprehensively support the promotion of Sofwave’s products in the Chinese market.

Huatang Dachang will provide Sofwave with end-to-end professional commercial solutions, facilitating the registration and approval of Sofwave products with the National Medical Products Administration (NMPA) while accelerating their comprehensive commercialization in the Chinese market, including product promotion, distribution, and sales.

Louis Scafuri, CEO of Sofwave, stated, “We are delighted to partner with Huatang Dachang to jointly accelerate the development of Sofwave products in China. Sofwave highly recognizes Huatang Dachang’s end-to-end solution capabilities, as well as its high-quality and extensive distribution network. The Chinese medical aesthetics market has currently reached a size of $29 billion and continues to grow at a double-digit compound annual growth rate, far outpacing other countries and regions worldwide. For Sofwave, the Chinese market holds significant strategic importance.”

Sofwave is the global market leader in ultrasound-based anti-aging treatments. Sofwave products leverage the world’s only innovative 3D volumetric ultrasound technology (Intense Ultrasound Beam Technology), which delivers energy to the dermis via seven high-energy, parallel, low-scatter ultrasound beams. This approach not only addresses fine lines and wrinkles in a single session but also lifts the eyebrows and tightens lax tissue along the jawline and neck. The ultrasound parallel beam technology employed by Sofwave has been cleared by the U.S. Food and Drug Administration (FDA), ensuring non-invasive treatments with no downtime while delivering effective anti-aging results, thereby achieving true safety and reliability.

Driven by Sofwave’s exceptional market performance and outstanding customer satisfaction globally, its entry into the Chinese market will not only provide Chinese consumers with effective, safe, painless, and non-invasive anti-aging treatment solutions but also further expand the penetration of energy-based anti-aging therapies in China. With sales of energy-based medical aesthetic devices in China growing at a compound annual growth rate (CAGR) of nearly 20%, coupled with rising consumer demand for skin tightening and rejuvenation, the market for these devices in China is projected to reach a scale of tens of billions of RMB.

As China’s leading cross-border commercial solutions platform, Warton Dachang is dedicated to providing professional market access and commercialization solutions for high-value medical devices. It currently boasts a network of over 500 distributors and covers more than 1,700 healthcare institutions across China. Warton Dachang is wholly owned by Warburg Pincus, a global leading private equity investment firm.

Cheng Xuehui, CEO of Huatang Dachang, stated, “We are honored to enter into a strategic partnership with Sofwave, whose products have garnered widespread acclaim in the global medical aesthetics industry. As a leading end-to-end commercialization platform, Huatang Dachang will leverage its extensive experience and expertise accumulated over years in the high-value medical device sector to work closely with Sofwave in introducing its globally leading products to the Chinese market, thereby achieving outstanding performance.”

Huatang Dachang is a leading cross-border commercial solutions platform in China, providing end-to-end professional commercial solutions for high-value medical devices. Its services cover product registration, import and export, warehousing and distribution, commercial channel management, inventory management, and after-sales management. The company has accumulated extensive experience in serving global brands engaged in cross-border business. It has established long-term partnerships with numerous clients, covering high-value medical device brands across multiple medical specialties, including ophthalmology, in vitro diagnostics (IVD), orthopedics, cardiology, neurology, obstetrics and gynecology, vascular surgery, endocrinology, pulmonology, and high-value medical consumables. Clients include globally leading brands such as Alcon, MicroVention, Illumina, Smith & Nephew, Roche, Abbott, and Procter & Gamble. Welcome to visit.http://www.htdkgroup.com/Learn more.

Sofwave Medical employs proprietary, breakthrough technology to reduce and improve wrinkles in an innovative way. Its Synchronous Ultrasound Parallel Beam (SUPERB™) technology, cleared by the U.S. Food and Drug Administration (FDA), is indicated for the improvement of fine lines and wrinkles on the face, as well as for lifting the eyebrows and lax tissue in the submental (below the chin) and neck areas, offering a smart, simple, effective, and safe aesthetic solution.